Literature DB >> 11375941

Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings.

D Sifrim1, R Holloway, J Silny, Z Xin, J Tack, A Lerut, J Janssens.   

Abstract

BACKGROUND & AIMS: Gastroesophageal reflux can be acid, nonacid, pure liquid, or a mixture of gas and liquid. We investigated the prevalence of acid and nonacid reflux and the air-liquid composition of the refluxate in ambulant healthy subjects and patients with reflux disease (GERD).
METHODS: Twenty-four-hour ambulatory recordings were performed in 30 patients with symptomatic GERD and erosive esophagitis and in 28 controls. Esophageal pH and impedance were used to identify acid reflux (pH drop below 4.0), minor acid reflux (pH drop above 4.0), nonacid reflux (pH drop less than 1 unit + liquid reflux in impedance), and gas reflux.
RESULTS: The total rate of gastroesophageal reflux episodes was similar in patients and controls. Patients with GERD had a higher proportion (45% vs. 33%) and rate of acid reflux than controls (21.5 [9-35]/24 h vs. 13 [6.5-21]/24 h; P < 0.05). One third of reflux events was nonacid in both groups. Mixed reflux of gas and liquid was the most frequent pattern with gas preceding liquid in 50%-80% of cases. Pure liquid reflux was more often acid in patients with GERD than controls (45% vs. 32%; P < 0.05).
CONCLUSIONS: Reflux of gastric contents was similarly frequent in patients with GERD and controls. Although there was no difference in the overall number of reflux episodes, more acidic reflux occurred in symptomatic patients with GERD, suggesting differences in gastric acid secretion or distribution.

Entities:  

Mesh:

Year:  2001        PMID: 11375941     DOI: 10.1053/gast.2001.24841

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  83 in total

Review 1.  Functional heartburn: the stimulus, the pain, and the brain.

Authors:  R Fass; G Tougas
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

Review 2.  Cough. 3: chronic cough and gastro-oesophageal reflux.

Authors:  G A Fontana; M Pistolesi
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139

Review 3.  Pediatric otolaryngologic manifestations of gastroesophageal reflux disease.

Authors:  Mark A Gilger
Journal:  Curr Gastroenterol Rep       Date:  2003-06

Review 4.  Acid rereflux: a review, emphasizing detection by impedance, manometry, and scintigraphy, and the impact on acid clearing pathophysiology as well as interpreting the pH record.

Authors:  Steven S Shay; Lawrence F Johnson; Joel E Richter
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

Review 5.  Cough . 6: Which investigations are most useful in the diagnosis of chronic cough?

Authors:  L P A McGarvey
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

Review 6.  Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation.

Authors:  Arne Kandulski; Peter Malfertheiner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-22       Impact factor: 46.802

7.  Impact of bolus volume on small intestinal intra-luminal impedance in healthy subjects.

Authors:  Nam Q Nguyen; Laura K Bryant; Carly M Burgstad; Robert-J Fraser; Daniel Sifrim; Richard H Holloway
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

8.  Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions--a debate: pro.

Authors:  Tomás Navarro-Rodriguez; Ronnie Fass
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

Review 9.  Cough. 1: Chronic cough in adults.

Authors:  A H Morice; J A Kastelik
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

10.  Therapeutic effects of laparoscopic fundoplication for nonerosive gastroesophageal reflux disease.

Authors:  Nobuo Omura; Hideyuki Kashiwagi; Fumiaki Yano; Kazuto Tsuboi; Yoshio Ishibashi; Naruo Kawasaki; Yutaka Suzuki; Katsuhiko Yanaga
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.